InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
-0.25%
)
US TECH 100
19,239.60
(
-0.10%
)
Dow Jones
39,134.76
(
0.77%
)
Brent Oil
84.90
(
-0.13%
)
Bitcoin
64,065.29
(
-1.17%
)
Post# of 252279
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: genisi post# 127457

Wednesday, 09/28/2011 5:25:45 AM

Wednesday, September 28, 2011 5:25:45 AM

Post# of 252279
UTHR:

Yeah the study was also a longer duration (24 weeks) then past approved PAH therapies (12 or 16). Still I think the results on the surface looked quite good. I doubt much impact on IV/sub-q use.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up